Symbol
| CMSP
|
Location
| 11p11.2
|
Name
|
congenital myasthenic syndrome, post synaptic |
Other name(s)
|
congenital myasthenic syndrome 11 |
Corresponding gene
|
RAPSN
|
Other symbol(s)
| CMS1D, FADS, CMS11
|
Main clinical features
|
disorders of the neuromuscular junction
associated with acetylcholine receptor deficiency, presentation in childhood age with arthrogryposis, ptosis and mild proximal limb weakness
antibodies to AChR were absent and response to anticholinesterase inhibitors was favorable.; at EMG a decrement in the CMAP, and at muscle biopsy a decrease in the amplitude of miniature endplate potentials (MEPP) and a reduction in the number of endplate AChR |
Genetic determination
| autosomal recessive |
Function/system disorder
| neuromuscular |
| neurology |
Type
| disease
|
Gene mutation | Chromosome rearrangement | Effect | Comments |
|
---|
missense
|  
| truncated protein
| . mutation N88K homozygous or heterozygous for N88K and a second mutation (either L14P, 46insC, or Y269X
. mild to moderate myasthenic symptoms with favorable response to anticholinesterase treatment
| deletion
|  
|  
| Alu-mediated unequal homologous recombination may have caused the deletion
| |